Literature DB >> 8981205

Risk factors for the development of obliterative bronchiolitis after lung transplantation.

R E Girgis1, I Tu, G J Berry, H Reichenspurner, V G Valentine, J V Conte, A Ting, I Johnstone, J Miller, R C Robbins, B A Reitz, J Theodore.   

Abstract

BACKGROUND: Acute rejection has emerged as an important risk factor for obliterative bronchiolitis after lung transplantation. We performed a multivariate analysis to assess the impact of additional variables.
METHODS: Seventy-four recipients (48 heart-lung, 18 single-lung, and 8 bilateral-lung recipients) who survived longer than 90 days and underwent transplantation more than 15 months before data analysis were included in this study. Several variables were entered into a Cox regression analysis to determine their association with the development of bronchiolitis obliterans syndrome.
RESULTS: Bronchiolitis obliterans syndrome developed in 48 (65%) of 74 patients. Significant correlations were detected for acute rejection score, defined as the sum of pathologic grades of each separate acute rejection episode (p = 0.0004, likelihood ratio test value = 12.4) and for lymphocytic bronchiolitis (p = 0.03). In a bivariate model, episodes of organizing pneumonia and bacterial or fungal pneumonia significantly increased the likelihood ratio test value of the acute rejection score. The addition of the cytomegalovirus infection score, reflecting the frequency and severity of infection, to the combination of the acute rejection score and episodes of bacterial or fungal pneumonia resulted in a further significant increase in the likelihood ratio test value. Significant risk factors for moderate to severe stages of airflow limitation were at least one episode of acute rejection of grade > or = 2, younger recipient age, and any acute rejection episode 180 days or longer after transplantation.
CONCLUSIONS: Increasing frequency and severity of acute rejection episodes are strongly associated with the development of bronchiolitis obliterans syndrome. Lymphocytic bronchiolitis appeared to be significant by univariate analysis, but in a two-risk factor model, it did not augment the influence of acute rejection. Organizing pneumonia, bacterial or fungal pneumonia, and increasing severity and frequency of cytomegalovirus infections potentiate the effect of acute rejection. Late episodes of acute rejection and younger recipient age increase the risk for development of advanced disease.

Entities:  

Mesh:

Year:  1996        PMID: 8981205

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  46 in total

Review 1.  New immunosuppressive drugs and lung transplantation: last or least?

Authors:  J W van den Berg; D S Postma; G H Koëter; W van der Bij
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

2.  The protective role of laparoscopic antireflux surgery against aspiration of pepsin after lung transplantation.

Authors:  P Marco Fisichella; Christopher S Davis; Peter W Lundberg; Erin Lowery; Ellen L Burnham; Charles G Alex; Luis Ramirez; Karen Pelletiere; Robert B Love; Paul C Kuo; Elizabeth J Kovacs
Journal:  Surgery       Date:  2011-10       Impact factor: 3.982

3.  Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-α-dependant interleukin-17.

Authors:  Joseph Weber; Venkataswarup Tiriveedhi; Masashi Takenaka; Wei Lu; Ramsey Hachem; Elbert Trulock; G Alec Patterson; T Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2012-01-29       Impact factor: 10.247

Review 4.  Human and murine obliterative bronchiolitis in transplant.

Authors:  John F McDyer
Journal:  Proc Am Thorac Soc       Date:  2007-01

5.  Respiratory virus-induced dysregulation of T-regulatory cells leads to chronic rejection.

Authors:  Ankit Bharat; Elbert Kuo; Deepti Saini; Nancy Steward; Ramsey Hachem; Elbert P Trulock; G Alexander Patterson; Bryan F Meyers; Thalachallour Mohanakumar
Journal:  Ann Thorac Surg       Date:  2010-11       Impact factor: 4.330

Review 6.  Mechanisms of chronic rejection in cardiothoracic transplantation.

Authors:  Matthew J Weiss; Joren C Madsen; Bruce R Rosengard; James S Allan
Journal:  Front Biosci       Date:  2008-01-01

7.  Transcript signatures of lymphocytic bronchitis in lung allograft biopsy specimens.

Authors:  Xiang Xu; Jeffrey A Golden; Gregory Dolganov; Kirk D Jones; Samantha Donnelly; Timothy Weaver; George H Caughey
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

Review 8.  Cardiac allograft vasculopathy and insulin resistance--hope for new therapeutic targets.

Authors:  Luciano Potena; Hannah A Valantine
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

9.  Both Pre-Transplant and Early Post-Transplant Antireflux Surgery Prevent Development of Early Allograft Injury After Lung Transplantation.

Authors:  Wai-Kit Lo; Hilary J Goldberg; Jon Wee; P Marco Fisichella; Walter W Chan
Journal:  J Gastrointest Surg       Date:  2016-01       Impact factor: 3.452

10.  Minimal acute rejection in pediatric lung transplantation--does it matter?

Authors:  Christian Benden; Albert Faro; Sarah Worley; Susana Arrigain; Paul Aurora; Manfred Ballmann; Debra Boyer; Carol Conrad; Irmgard Eichler; Okan Elidemir; Samuel Goldfarb; George B Mallory; Peter J Mogayzel; Daiva Parakininkas; Melinda Solomon; Gary Visner; Stuart C Sweet; Lara A Danziger-Isakov
Journal:  Pediatr Transplant       Date:  2010-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.